Human papilloma virus and lupus: The virus, the vaccine and the disease

Yahel Segal*, Michele Calabrò, Darja Kanduc, Yehuda Shoenfeld

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Purpose of review Systemic lupus erythematosus (SLE) is a well known, widespread autoimmune disease, involving multiple organ systems, with a multifaceted, widely unmapped etiopathogenesis. Recently, a new aspect of morbidity has been described among SLE patients: infection with human papilloma virus (HPV). We set out to review data regarding the intricate relationship between the two and attempt to determine whether HPV may pose as a contributing factor to the development of SLE. Recent findings We relate to epidemiological, molecular and clinical data. We have found evidence in all these fields suggesting HPV to be involved in the pathogenesis of SLE: increased prevalence of HPV infection among SLE patients; vast molecular homology between viral peptides and human proteins associated with SLE; several reports of SLE development post-HPV vaccination. Our findings suggest a possible involvement of HPV infection in the induction of SLE, via a mechanism of immune cross-reaction due to molecular homology. Summary We review clinical, epidemiological and molecular data suggesting involvement of HPV infection in the pathogenesis of SLE. We suggest that these findings may justify the development of new HPV vaccines containing viral peptides that bear no homology to the human proteome, in order to avoid possible adverse immune cross-reactivity.

Original languageEnglish
Pages (from-to)331-342
Number of pages12
JournalCurrent Opinion in Rheumatology
Issue number4
StatePublished - 1 Jul 2017


  • autoimmunity
  • cross-reactivity
  • human papilloma virus
  • molecular homology
  • systemic lupus erythematosus


Dive into the research topics of 'Human papilloma virus and lupus: The virus, the vaccine and the disease'. Together they form a unique fingerprint.

Cite this